TSXV:SQD.H - Post Discussion
Post by
FactFinder1994 on Apr 04, 2023 8:56am
The WORLD is adopting Shaf Keshavjee's protocols
& SQI's TOR-Dx is an integral piece of the pie.
Shaf is THE KEY OPIONION LEADER here and he hand picked SQI for its important contribution.
Dr. Keshavjee’s past achievements and expertise are perfectly matched to inform and guide the adoption of new technologies at UHN. He has led clinical and research teams in lung transplantation, resulting in significant advances in the field and the translation of novel applications across organ transplantation. His pioneering research to recondition and repair injured human donor lungs with the Toronto Ex Vivo Lung Perfusion system has more than doubled the number of lung transplants performed each year at UHN. This technology is now being used at transplant centres around the world, including Asia, Australia, South America, Europe and the United States, and at leading centres such as Duke, Johns Hopkins, Cleveland Clinic and the Mayo Clinic. New chief appointed at UHN TechnaCanadian Healthcare Technologyhttps://www.canhealth.com › 2022 › April › 13
Be the first to comment on this post